Research on pharmaceutical management provisions in the Evaluation Standards for Third-level Maternal and Child Health Care Hospitals in Hubei Province （2024 Edition）
- VernacularTitle:《湖北省三级妇幼保健院评审标准（2024年版）》药事管理条款研究
- Author:
Linlin ZHAO
1
;
Yuanyuan LU
2
;
Maochang LIU
3
;
Fan JIN
4
;
Liangfang PANG
2
;
Wei FU
5
Author Information
1. Dept. of Clinical Pharmacy，General Hospital of Central Theater Command，Wuhan 430070，China
2. Dept. of Pharmacy，Women and Children’s Hospital of Hubei Province，Wuhan 430064，China
3. Dept. of Pharmacy，Wuhan Children’s Hospital，Wuhan 430019，China
4. Dept. of Pharmacy，Yichang Women and Children’s Hospital，Hubei Yichang 443000，China
5. Dept. of Pharmacy，Tongji Hospital，Tongji Medical College of Huazhong University of Science and Technology，Wuhan 430030，China
- Publication Type:Journal Article
- Keywords:
maternal and child health care hospitals;
hospital evaluation standards;
pharmaceutical management;
special group
- From:
China Pharmacy
2024;35(23):2858-2862
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To study pharmaceutical management provisions in the Evaluation Standards for Third-level Maternal and Child Health Care Hospitals in Hubei Province （2024 Edition） （hereinafter referred to as 2024 Edition of Hubei Maternal and Child Health Care Standards）. METHODS The formulation of pharmaceutical management clauses and management rules in the 2024 Edition of Hubei Maternal and Child Health Care Standards was elaborated and compared with the pharmaceutical management clauses in the Evaluation Standards for Third-level Maternal and Child Health Care Hospitals （2016 Edition） to find out their similarities and differences； the basis for the formulation of unique pharmaceutical management clauses was analyzed， so as to propose further improvement suggestions. RESULTS & CONCLUSIONS Compared with the Evaluation Standards for Third- level Maternal and Child Health Care Hospitals （2016 Edition）， the similarities in pharmaceutical management in the 2024 Edition of Hubei Maternal and Child Health Care Standards were mainly reflected in the relevant laws， regulations， rules and personnel requirements that should be followed， the full process management of drug procurement， reserve， storage and recall， drug dispensing and formulation management， etc. The unique provisions of the 2024 Edition of Hubei Maternal and Child Care Standards were mainly reflected in the establishment of children’s medication working group， the establishment of a list of children’s specific drugs， the development of surplus drug management system， and the management of off-label drug use， etc. The formulation of unique provisions for pharmaceutical management not only conformed to the newly released policy requirements in recent years， but also combined the characteristics and actual situation of maternal and child health care hospitals. 2024 Edition of Hubei Maternal and Child Health Care Standards should be further improved in terms of strengthening detail management and enhancing the rational application management of traditional Chinese medicine.
